Company & Sponsor Intelligence
Spanish Foundation for Neurometrics Development
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed4
Countries3
Therapeutic footprint
adhdautismout_of_scope
Indexed studies
NCT01876524tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients
adhd · SpainNA
adhd · SpainNA
NCT06368726Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders
out_of_scope · United StatesPHASE1, PHASE2
out_of_scope · United StatesPHASE1, PHASE2
NCT02614599Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet
adhd · EARLY_PHASE1
adhd · EARLY_PHASE1
NCT02004236Fronto-temporal tDCS Mproves Fluency & Empathy in ASD Kids
autism · United KingdomNA
autism · United KingdomNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →